Publications:59
Mary Jane Potash, PhD
About Me
Mary Jane Potash obtained her AB from Wellesley College and her PhD from Brown University. She trained at the Basel Institute of Immunology and served on the faculty of Harvard Medical School and Columbia University Medical Center before the merger between Mt Sinai and St. Luke's-Roosevelt Hospital. Since 1988 her research has focused on HIV replication and control.
Language
English
Position
PROFESSOR | Medicine, Infectious Diseases, PROFESSOR | Pathology, Molecular and Cell Based Medicine
Awards
1987
Staff Award, Institute of Medicine, National Academy of Sciences
Publications
Selected Publications
- EcoHIV Infection of Primary Murine Brain Cell Cultures to Model HIV Replication and Neuropathogenesis. Boe Hyun Kim, Wei Chao, Eran Hadas, Alejandra Borjabad, Mary Jane Potash, David J. Volsky. Viruses
- Innate immune responses reverse HIV cognitive disease in mice: Profile by RNAseq in the brain. Alejandra Borjabad, Baojun Dong, Wei Chao, David J. Volsky, Mary Jane Potash. Virology
- CCL2 is required for initiation but not persistence of HIV infection mediated neurocognitive disease in mice. Boe Hyun Kim, Eran Hadas, Jennifer Kelschenbach, Wei Chao, Chao Jiang Gu, Mary Jane Potash, David J. Volsky. Scientific Reports
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Potash has not yet completed reporting of Industry relationships.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.